MedElevator Войти в исследования
← Поиск публикаций

DOI 10.12998/wjcc.v11.i32.7770

Медицинская библиотека · World journal of clinical cases · 2023

Clinical study of NFNC in the treatment of acute exacerbation chronic obstructive pulmonary disease patients with respiratory failure.

Chen Xiang, Dai Ling, Ma Jin-Zhu, Chu Xin-Xu, Dai Liang, Liu Jian-Ming, Guo Si-Wei, Ru Xin-Wei, Zhuang Xue-Shi

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Most patients with acute exacerbation chronic obstructive pulmonary disease (AECOPD) have respiratory failure that necessitates active correction and the improvement of oxygenation is particularly important during treatment. High flow nasal cannula (HFNC) oxygen therapy is a non-invasive respiratory aid that is widely used in the clinic that improves oxygenation state, reduces dead space ventilation and breathing effort, protects the loss of cilia in the airways, and improves patient comfort.

AIM: To compare HFNC and non-invasive positive pressure ventilation in the treatment of patients with AECOPD.

METHODS

Eighty AECOPD patients were included in the study. The patients were in the intensive care department of our hospital from October 2019 to October 2021. The patients were divided into the control and treatment groups according to the different treatment methods with 40 patients in each group. Differences in patient comfort, blood gas analysis and infection indices were analyzed between the two groups.

RESULTS

After treatment, symptoms including nasal, throat and chest discomfort were significantly lower in the treatment group compared to the control group on the 3rd and 5th days (P < 0.05). Before treatment, the PaO2, PaO2/FiO2, PaCO2, and SaO2 in the two groups of patients were not significantly different (P > 0.05). After treatment, the same indicators were significantly improved in both patient groups but had improved more in the treatment group compared to the control group (P < 0.05). After treatment, the white blood cell count, and the levels of C-reactive protein and calcitonin in patients in the treatment group were significantly higher compared to patients in the control group (P < 0.05).

CONCLUSION

HFNC treatment can improve the ventilation of AECOPD patients whilst also improving patient comfort, and reducing complications. HFNC is a clinically valuable technique for the treatment of AECOPD.

Для цитирования: Chen Xiang, Dai Ling, Ma Jin-Zhu, Chu Xin-Xu, Dai Liang, Liu Jian-Ming, Guo Si-Wei, Ru Xin-Wei, Zhuang Xue-Shi. Clinical study of NFNC in the treatment of acute exacerbation chronic obstructive pulmonary disease patients with respiratory failure.. World journal of clinical cases. 2023. DOI: 10.12998/wjcc.v11.i32.7770.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.